(Q37901244)

25 August 2017

1 reference

title

Matrix elastin: a promising biomarker for chronic obstructive pulmonary disease (English)

1 reference

chronic obstructive pulmonary disease

25 August 2017

0 references

0 references

isodesmosine

1 reference

ChEBI release 2020-05-28

5

Maurizio Luisetti

1 reference

25 August 2017

Gerard M Turino

1

1 reference

25 August 2017

Shuren Ma

series ordinal

2

1 reference

25 August 2017

Yong Y Lin

series ordinal

3

1 reference

25 August 2017

Jerome O Cantor

series ordinal

4

1 reference

25 August 2017

language of work or name

English

0 references

publication date

1 September 2011

1 reference

American Journal of Respiratory and Critical Care Medicine

25 August 2017

1 reference

25 August 2017

184

1 reference

25 August 2017

6

1 reference

25 August 2017

637-641

1 reference

Global burden of COPD: risk factors, prevalence, and future trends

25 August 2017

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201103-0450PP

Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201103-0450PP

Statins in COPD: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201103-0450PP

Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201103-0450PP

Prevention of exacerbations of chronic obstructive pulmonary disease with tiotropium, a once-daily inhaled anticholinergic bronchodilator: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201103-0450PP

Considerations in the evaluation of surrogate endpoints in clinical trials. summary of a National Institutes of Health workshop

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201103-0450PP

Elastin structure, biosynthesis, and relation to disease states

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201103-0450PP

Marked longevity of human lung parenchymal elastic fibers deduced from prevalence of D-aspartate and nuclear weapons-related radiocarbon

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201103-0450PP

The detection and quantitation of free desmosine and isodesmosine in human urine and their peptide-bound forms in sputum

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201103-0450PP

Cellular and connective tissue changes in alveolar septal walls in emphysema

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201103-0450PP

Clinical features and history of the destructive lung disease associated with alpha-1-antitrypsin deficiency of adults with pulmonary symptoms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201103-0450PP

Elastinolytic activity of human cathepsin L.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201103-0450PP

Elastin degradation by mononuclear phagocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201103-0450PP

Degradation of connective tissue matrices by macrophages. III. Morphological and biochemical studies on extracellular, pericellular, and intracellular events in matrix proteolysis by macrophages in culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201103-0450PP

Roles for proteinases in the pathogenesis of chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201103-0450PP

alpha 1-Antitrypsin: molecular pathology, leukocytes, and tissue damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201103-0450PP

Human plasma proteinase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201103-0450PP

The regulation of matrix metalloproteinases and their inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201103-0450PP

The tissue inhibitors of metalloproteinases (TIMPs): an ancient family with structural and functional diversity

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201103-0450PP

Urinary excretion of elastin peptides containing desmosin after intratracheal injection of elastase in hamsters

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201103-0450PP

Desmosine as a biomarker of elastin degradation in COPD: current status and future directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201103-0450PP

MEKC of desmosine and isodesmosine in urine of chronic destructive lung disease patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201103-0450PP

Quantitation of desmosine and isodesmosine in urine, plasma, and sputum by LC-MS/MS as biomarkers for elastin degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201103-0450PP

Measurement of urinary total desmosine and isodesmosine using isotope-dilution liquid chromatography-tandem mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201103-0450PP

The effect of tiotropium therapy on markers of elastin degradation in COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201103-0450PP

Chemotactic activity of elastin-derived peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201103-0450PP

Val-Gly-Val-Ala-Pro-Gly, a repeating peptide in elastin, is chemotactic for fibroblasts and monocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201103-0450PP

Elastin fragments drive disease progression in a murine model of emphysema

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201103-0450PP

Peptide sequences selected by BA4, a tropoelastin-specific monoclonal antibody, are ligands for the 67-kilodalton bovine elastin receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201103-0450PP

The 67-kDa enzymatically inactive alternatively spliced variant of beta-galactosidase is identical to the elastin/laminin-binding protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201103-0450PP

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201103-0450PP

10.1164/RCCM.201103-0450PP

21 January 2018

Identifiers

DOI

1 reference

25 August 2017

1 reference